Connect with us

Technology

Faculty Introduces the Frontier Life Sciences Developer Studio, Giving Clinical Trial Teams a Faster Path to Simulation-Driven Decision Intelligence

Published

on

The latest release for Faculty Frontier™ introduces an enhanced development environment for life sciences decision engineers to build, validate, and deploy Computational Twins with greater speed and confidence.

LONDON, June 16, 2026 /PRNewswire/ — Faculty, the developer of the Decision Intelligence platform Faculty Frontier™, today announced the launch of the Frontier Life Sciences Developer Studio – a purpose-built environment with the latest tooling to configure a Computational Twin (CT) for clinical trial simulation. For life sciences organisations, this release empowers technical teams to rapidly iterate and expand Frontier deployments – connecting decisions across the trial lifecycle to deliver better medicines to patients, faster.

“Working closely with our life sciences customers, we’ve seen firsthand how Decision Intelligence is reshaping what’s possible in clinical trial performance,” said Andy Brookes, Chief Technology Officer and Co-Founder of Faculty. “The Frontier Life Sciences Developer Studio is the next step in that journey, giving clinical trial teams the latest environment they need to develop and iterate a Computational Twin – Frontier’s proprietary composite AI framework for simulating and optimising complex decisions at scale.”

Life sciences organisations are coordinating increasingly complex trial programmes across sites, geographies, and therapeutic areas – yet development functions continue to rely on siloed tools, inconsistent assumptions, and manual processes. The cost of this fragmentation is that trial design cycles can take months, contributing to persistent recruitment bottlenecks, and limited visibility for timely intervention.

By integrating data, models, and operational workflows into a unified simulation layer, leading pharma organisations are using Frontier to compress planning cycles from weeks to minutes, run better, faster trials with fewer amendments, and optimise portfolio outcomes against key KPIs. As Decision Intelligence scales across R&D, the speed at which teams can expand simulation-led capabilities is becoming a critical competitive advantage. The Frontier Life Sciences Developer Studio is designed to meet this need.

A Purpose-Built Environment to Configure Clinical Trial Simulation

The Life Sciences Developer Studio compresses the time and team size required to encode clinical trial decision-making in software. Teams can rapidly run, test, and validate CT development work to confirm clinical trial simulations run correctly, and reconcile with real-world data.

The Studio also simplifies how teams build and publish new decision applications, integrate with existing clinical development systems, and incorporate new or retrained models as trial data evolves.

AI Agents for Validation and Debugging

Embedded AI agents actively support CT development by diagnosing bugs, triangulating discrepancies across data streams, and suggesting fixes in real time.

In the clinical trial context – where data streams span CTMS exports, patient enrolment events, and site activation logs – automated triangulation significantly reduces debugging time, and increases confidence before changes reach production.

What This Means for Life Sciences Teams

For the decision engineers and scientists at the heart of Frontier deployments, the Developer Studio delivers:

A faster path from CT development to real-world clinical trial optimisationConfidence in simulation outputs, with reduced debugging and validation overheadSeamless integration with existing clinical systems, data infrastructure, and modelsA scalable foundation to build and publish new decision applications – extending Decision Intelligence capabilities across programmes, functions, and geographies

Availability

The Life Sciences Developer Studio is available to all Frontier life sciences customers and partners. To explore how your team can begin with the Studio, speak to your Frontier solutions engineer. New to Frontier? Visit faculty.ai/frontier to learn how organisations are using Decision Intelligence to transform performance and scale AI across the enterprise.

About Faculty

Founded in 2014, Faculty is one of Europe’s longest standing applied AI companies. Our suite of AI products spans everything organisations need to access frontier AI and get it into the hands of their frontline teams to support their most important work. Faculty is also the developer of Faculty Frontier™, a Decision Intelligence Platform used by some of the world’s most trusted brands to transform decision-making at scale.

Widely recognised as a leader in AI safety, we work for the world’s leading AI labs, such as OpenAI, Anthropic and Meta, to ensure their latest models are safe, human-led and explainable. Our PhD-heavy team of deep AI experts has delivered hundreds of real-world AI products to improve critical public services and drive sustained economic returns across every sector of the economy. Headquartered in London, Faculty remains founder-led following its acquisition by Accenture in 2026.

 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/faculty-introduces-the-frontier-life-sciences-developer-studio-giving-clinical-trial-teams-a-faster-path-to-simulation-driven-decision-intelligence-302801383.html

Continue Reading

Technology

NatGold Digital Announces Immediate Delisting of NATG from MEXC Following U.S. Treasury Action

Published

on

By

CORAL GABLES, Fla., Nov. 7, 2026 /PRNewswire/ — NatGold Digital Ltd. (“NatGold” or the “Company”) today announced that it has requested the delisting of the NatGold Token (NATG) from MEXC, a global cryptocurrency exchange where NATG is currently listed, with immediate effect.

The decision follows the U.S. Department of the Treasury’s announcement of an order issued by its Financial Crimes Enforcement Network (FinCEN) under the Combating Russian Money Laundering Act, prohibiting U.S. financial institutions from processing funds transfers involving MEXC Global.

NatGold is a U.S. company whose wholly owned subsidiary, NatGold Integrity Vault LLC, is registered with FinCEN as a money services business. The Company is acting ahead of the order’s effective date.

“As a U.S. company operating through a FinCEN-registered money services business, we are acting immediately in response to Treasury’s decision,” said Mark Radke, Executive Chairman of NatGold Digital. “Trust is a cornerstone of NatGold’s operating structure, and responding promptly to this regulatory action reflects that commitment.”

NatGold is in advanced discussions with multiple regulatory-compliant exchanges and venues  serving global markets, including the United States, and intends to replace MEXC as soon as possible. Once new listings are confirmed, NATG token holders will be advised of the arrangements and encouraged to register accounts and link their wallets, as applicable, to continue trading.

About NatGold Digital Ltd.

NatGold Digital Ltd. is the global leader in digital gold mining and the architect and operator of a patent-pending, non-extractive platform designed to unlock the intrinsic value of technically verified in-ground gold resources that remain securely stored in Mother Nature’s Vault. NatGold Tokens are structured to represent standardized unit interests in NatGold Certified Resources, disclosed under internationally recognized geological Technical Reports — without physical extraction, processing, or movement of gold. The result is a superior fiat money alternative designed to help lead a global monetary reformation.

For additional background, please visit NatGold.com or our official YouTube channel for videos and information about our digital mining ecosystem: youtube.com/@NatGold_Digital.

Contact

Media@NatGold.com
InvestorServices@NatGold.com
+1 (646) 825-3038

The information in the above release has been prepared by NatGold Digital Ltd. (“NatGold”) using its best efforts to realistically and factually present the information contained herein. However, subjective opinion, reliance on factors outside NatGold’s control, and external information sources unavoidably mean that NatGold cannot warrant the information to be exhaustive, complete, or sufficient. The information provided herein is intended solely for general informational purposes and does not constitute an offer or solicitation for the purchase or sale of any shares or securities of NatGold or for the purchase or sale of any NatGold Tokens. NatGold Tokens are not intended to be “securities” in any jurisdiction, and NatGold makes no claim or representation related to the value of NatGold or NatGold Tokens. Potential investors should seek advice from a qualified financial dealer before investing in NatGold. There are substantial risks associated with investing in development-stage digital assets and technology companies.

View original content to download multimedia:https://www.prnewswire.com/news-releases/natgold-digital-announces-immediate-delisting-of-natg-from-mexc-following-us-treasury-action-302932601.html

SOURCE NatGold Digital Ltd.

Continue Reading

Technology

What to Look for in an Online GLP-1 Provider: Meant Outlines Five Questions Worth Asking Before Signing Up

Published

on

By

MANASSAS, Va., Nov. 7, 2026 /PRNewswire/ — As more telehealth companies offer GLP-1 care, the options can look alike from the outside, and telling them apart takes more than a glance at a landing page. Meant is sharing five questions consumers can ask when choosing an online GLP-1 provider, along with how it approaches each one.

Five Questions Worth Asking

Who makes the clinical decisions? A trustworthy provider should be clear about which licensed clinicians review each person’s information. At Meant, those decisions are made by licensed providers through its clinical partner, OpenLoop Health.Is there a real evaluation first? Look for a health-history review before anything is prescribed, and for plain language that a prescription is never guaranteed. Meant’s online assessment covers health history, current medications, and goals.Can the company’s credentials be checked? Independent certifications are one signal consumers can verify for themselves. Meant displays the seal for its LegitScript certification on its website.Is it clear who fills prescriptions? Providers should be open about the pharmacies they work with and whether those pharmacies are licensed in the United States.Is ongoing support spelled out, limits included? Good providers explain what follow-up looks like and who handles which questions. Meant pairs care with an optional Care Coach, and medical questions go to the care team.

A certification is a transparency signal, not a government approval or a promise about results, and no checklist replaces a conversation with a licensed clinician. Meant does not diagnose or prescribe, and treatment is not guaranteed for every applicant.

Take a Closer Look

Consumers who want to see how the assessment, clinical oversight, and coaching fit together can visit Meant‘s website and compare the details against the questions above.

About Meant

Meant is a health and wellness technology company focused on personalized GLP-1 weight-care support delivered through telehealth. The platform combines an online clinical assessment, licensed oversight through OpenLoop Health, Care Coach support, and supplemental wellness resources. Meant does not itself diagnose or prescribe; clinical decisions are made by its clinical partners. Learn more at meant.health.

Meant Health, Inc.
support@meant.health
1-512-879-9187
10199 Dean Drive, Manassas, VA 20110, USA

View original content:https://www.prnewswire.com/news-releases/what-to-look-for-in-an-online-glp-1-provider-meant-outlines-five-questions-worth-asking-before-signing-up-302927805.html

SOURCE Meant

Continue Reading

Technology

Capturing the Beauty of Anhui through Images–2026 Anhui Photography Season Concludes

Published

on

By

HUANGSHAN, China, Nov. 7, 2026 /PRNewswire/ — A news report from Crionline.

Spanning summer and autumn across three successive photography tours, the “Picturesque Anhui • Imaging Anhui” 2026 Anhui Photography Season officially wrapped up on November 4. Co-hosted by the Fédération Internationale de l’Art Photographique (FIAP), the Anhui Provincial Department of Culture and Tourism, and the Foreign Affairs Office of Anhui Provincial People’s Government, the event drew 116 photographers from 38 countries and regions. They visited 46 distinctive cultural and tourism attractions across five cities: Hefei, Chizhou, Anqing, Huangshan and Xuancheng. Through their lenses, they presented Anhui’s landscapes, cultural heritage and vibrant everyday life to the world.

Looking back on the three sessions: The first session kicked off in Hefei. Photographers documented the city’s innovation-driven urban landscape as well as the picturesque scenery and intangible cultural heritage of Chizhou’s ancient villages. The second session took them deep into Huangshan and Anqing. They explored time-honored Huizhou villages, magnificent mountains and Huangmei Opera culture, immersing themselves in Huizhou traditions and the cultural charm of the Yangtze River region in western Anhui. The concluding third session was held in Huangshan and Xuancheng, focusing on brilliant autumn hues, Huizhou‑style ancient architecture, and the traditional craftsmanship behind the Four Treasures of the Study.

From lush summer greens to rich autumn colours, the photographers produced more than 11,000 high‑resolution photographs. Reflecting the unique perspectives of international participants, these images will be disseminated globally in diverse forms. They will help tell compelling stories of Anhui’s cultural tourism and further boost the province’s international profile.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/capturing-the-beauty-of-anhui-through-images2026-anhui-photography-season-concludes-302932583.html

SOURCE Crionline

Continue Reading

Trending